People · Operator
Named in public records as an officer, director or promoter · active 2013–2022 · Biotechnology, Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cellanome, Inc. | — | Biotechnology | Series D+ | $213.7M | $2.0B | 2022 |
| Clear Labs, Inc. | — | Biotechnology | Series C | $135.8M | $218.3M | 2013 |
| BaseHealth, Inc. | — | Other Health Care | Series A | $13.6M | $91.7M | 2013 |
| CellarEye, Inc. | — | Other Technology | Pre-Seed | $955K | $19.5M | 2021 |
Kazutaka Ohno at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kazutaka Ohno on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mostafa Ronaghi | 4 | 8 |
| Farzad Naimi | 2 | 5 |
| Babak Yazdani | 1 | 18 |
| Arman Pahlavan | 1 | 12 |
| Gaurav Garg | 1 | 12 |
| Greg Yap | 1 | 8 |
| Rowan Chapman | 1 | 7 |
| Michael Taylor | 1 | 7 |
| Brian Hogan | 1 | 4 |
| Ming Fang | 1 | 4 |
| Mehdi Khodadad | 1 | 3 |
| Saeid Akhtari | 1 | 3 |
| Jason Pyle | 1 | 3 |
| Jay Flatley | 1 | 3 |
| Nader Sadrzadeh | 1 | 2 |
| Richard Murdock | 1 | 2 |
| Omead Ostadan | 1 | 1 |
| Kazutaka Kumar Ohno | 1 | 1 |
| Mostafa Kumar Ronaghi | 1 | 1 |
| Tarun Kumar Khurana | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.